留言板

尊敬的读者、作者、审稿人, 关于本刊的投稿、审稿、编辑和出版的任何问题, 您可以本页添加留言。我们将尽快给您答复。谢谢您的支持!

姓名
邮箱
手机号码
标题
留言内容
验证码

珍稀动物性药材替代策略及其科技创新与产业化进展

武文星 刘睿 郭盛 马宏跃 赵明 曹鹏 段金廒

武文星, 刘睿, 郭盛, 马宏跃, 赵明, 曹鹏, 段金廒. 珍稀动物性药材替代策略及其科技创新与产业化进展[J]. 南京中医药大学学报, 2022, 38(10): 847-856. doi: 10.14148/j.issn.1672-0482.2022.0847
引用本文: 武文星, 刘睿, 郭盛, 马宏跃, 赵明, 曹鹏, 段金廒. 珍稀动物性药材替代策略及其科技创新与产业化进展[J]. 南京中医药大学学报, 2022, 38(10): 847-856. doi: 10.14148/j.issn.1672-0482.2022.0847
WU Wen-xing, LIU Rui, GUO Sheng, MA Hong-yue, ZHAO Ming, CAO Peng, DUAN Jin-ao. Alternative Strategies for Precious Animal Derived Chinese Medicines Materials and Progress in Technological Innovation and Industrialization[J]. Journal of Nanjing University of traditional Chinese Medicine, 2022, 38(10): 847-856. doi: 10.14148/j.issn.1672-0482.2022.0847
Citation: WU Wen-xing, LIU Rui, GUO Sheng, MA Hong-yue, ZHAO Ming, CAO Peng, DUAN Jin-ao. Alternative Strategies for Precious Animal Derived Chinese Medicines Materials and Progress in Technological Innovation and Industrialization[J]. Journal of Nanjing University of traditional Chinese Medicine, 2022, 38(10): 847-856. doi: 10.14148/j.issn.1672-0482.2022.0847

珍稀动物性药材替代策略及其科技创新与产业化进展

doi: 10.14148/j.issn.1672-0482.2022.0847
基金项目: 

国家自然科学基金面上项目 81973450

国家重点研发计划 2018YFC1706100

江苏省高校“青蓝工程”中青年学术带头人; 江苏省农业科技自主创新项目 CX(22)3173

南京中医药大学中药学一流学科开放课题 2020YLXK009

详细信息
    作者简介:

    武文星, 女, 博士研究生, E-mail: 17688395387@163.com

    段金廒,教授,博士研究生导师,国际欧亚科学院院士。全国中医药杰出贡献奖获得者、全国优秀科技工作者,入选全国首届“岐黄学者”中医药领军人才工程,享受国务院政府特殊津贴。现任中药资源产业化与方剂创新药物国家地方联合工程中心主任、国家中医药管理局中药资源循环利用重点研究室主任、江苏省中药资源产业化过程协同创新中心主任,兼任中国自然资源学会中药及天然药物资源研究专业委员会主任委员、中国中药协会中药资源循环利用专业委员会主任委员等。先后7次入选Elsevier中国高被引学者榜单。作为第一授奖人荣获国家科技进步二等奖2项、部省级科技一等奖6项、江苏省教学成果奖二等奖1项

    通讯作者:

    段金廒, 男,教授, 博士生导师, 主要从事中药资源化学研究及资源循环利用研究, E-mail: dja@njucm.edu.cn

  • 中图分类号: R282.74

Alternative Strategies for Precious Animal Derived Chinese Medicines Materials and Progress in Technological Innovation and Industrialization

  • 摘要: 野生药用动物驯化养殖和珍稀濒危动物药的替代资源研究与开发是国家重大任务, 回顾和分析了我国动物药资源及替代研究的历史与现状, 提出了野生药用动物驯化养殖替代策略、基于中医药理论的药性与功效相似药材替代策略、基于动物种类亲缘学的同种属或近缘药材替代策略、基于药效成分组合的合成替代策略、基于生物学技术的合成替代策略等珍稀动物药替代方法, 以期为珍稀动物药替代品的研究提供借鉴与指引, 实现动物药资源的可持续发展与利用。

     

  • 图  1  我国动物性药材资源收录情况

    Figure  1.  The situation of animal derived medicinal materials in China

    图  2  珍稀动物性药材替代品的形成与发展

    Figure  2.  Formation and development of precious animal derived Chinese medicines substitutions

    图  3  珍稀动物性药材替代策略

    Figure  3.  Alternative strategies in precious animal derived Chinese mediciness

  • [1] 段金廒, 宿树兰, 郭盛, 等. 中药资源化学研究与资源循环利用途径及目标任务[J]. 中国中药杂志, 2015, 40(17): 3395-3401.

    DUAN JA, SU SL, GUO S, et al. Research on resources chemistry of Chinese medicinal materials and resources recycling utilization ways and goals and tasks[J]. China J Chin Mater Med, 2015, 40(17): 3395-3401.
    [2] 段金廒, 张伯礼, 宿树兰, 等. 基于循环经济理论的中药资源循环利用策略与模式探讨[J]. 中草药, 2015, 46(12): 1715-1722.

    DUAN JA, ZHANG BL, SU SL, et al. Strategy and mode of resources circulating utilization for Chinese materia medica based on circular economy theory[J]. Chin Tradit Herb Drugs, 2015, 46(12): 1715-1722.
    [3] 李西林, 张彤. 传承精华守正创新: 动物类中药的应用现状分析及未来发展思考[J]. 中医药管理杂志, 2022, 30(8): 5-7.

    LI XL, ZHANG T. Inheriting essence and keeping innovation-Application status analysis and future development of animal traditional Chinese medicine[J]. J Tradit Chin Med Manag, 2022, 30(8): 5-7.
    [4] 唐溱. 我国动物相关法律法规对动物类中药材利用与发展的影响[J]. 中草药, 2021, 52(24): 7718-7727.

    TANG Z. Influence of legislations related to animal on utilization and development of animal traditional Chinese medicine in China[J]. Chin Tradit Herb Drugs, 2021, 52(24): 7718-7727.
    [5] 冉俐, 王雪颖, 庄淑涵, 等. 《山海经》中医药成就管窥[J]. 中医药导报, 2018, 24(14): 7-10.

    RAN L, WANG XY, ZHUANG SH, et al. Achievements of traditional Chinese medicine in the classic of mountains and rivers[J]. Guid J Tradit Chin Med Pharm, 2018, 24(14): 7-10.
    [6] 周德生, 何清湖. 《五十二病方》释义[M]. 太原: 山西科学技术出版社, 2013.

    ZHOU DS, HE QH. Paraphrasis on Formulas for Fifty-two Diseases[M]. Taiyuan: Shanxi science and technology press, 2013.
    [7] 神农本草经[M]. 南京: 江苏凤凰科学技术出版社, 2019.

    Shen Nong's Classic of the Materia Medica[M]. Nanjing: Jiangsu phoenix science and technology press, 2019.
    [8] 陶弘景. 本草经集注[M]. 北京: 北京科学技术出版社, 2019: 1-13.

    TAO HJ. Collective commentaries on the classic of materia medica[M]. Beijing: Beijing science and technology press, 2019: 1-13.
    [9] 苏敬. 《新修本草》辑复[M]. 尚志钧, 辑校. 合肥: 安徽科学技术出版社, 2004: 216.

    SU J. Editing and restoration of Newly Revised Materia Medica[M]. SHANG ZJ, annoted. Hefei: Anhui science and technology publishing house, 2004: 216.
    [10] 李时珍. 本草纲目校点本[M]. 北京: 人民卫生出版社, 1982: 2845.

    LI SZ. Compendium of Materia Medica[M]. Beijing: People's medical publishing house, 1982: 2845.
    [11] 陈天羽, 杨学连, 陆昕怡, 等. 我国药用动物品种沿革与发展[J]. 中国中医药信息杂志, 2015, 22(3): 1-5.

    CHEN TY, YANG XL, LU XY, et al. Evolution and development of animal medicine varieties in China[J]. Chin J Inf Tradit Chin Med, 2015, 22(3): 1-5.
    [12] 张亚敏. 加入《濒危野生动植物种国际贸易公约》40周年我国积极推进履约行动成效瞩目[J]. 国土绿化, 2021(4): 47-48.

    ZHANG YM. On the 40th anniversary of China's accession to the Convention on International Trade in Endangered Species of Wild Fauna and Flora, China actively promoted the implementation of the Convention and achieved remarkable results[J]. Land Green, 2021(4): 47-48.
    [13] 唐溱. 我国动物相关法律法规对动物类中药材利用与发展的影响[J]. 中草药, 2021, 52(24): 7718-7727.

    TANG Z. Influence of legislations related to animal on utilization and development of animal traditional Chinese medicine in China[J]. Chin Tradit Herb Drugs, 2021, 52(24): 7718-7727.
    [14] 黄璐琦, 郭兰萍, 桑滨生, 等. 我国野生药材资源管理制度的分析及建议[J]. 中国中药杂志, 2009, 34(15): 1879-1885.

    HUANG LQ, GUO LP, SANG BS, et al. Analysis and suggestion management system of wild medicinal resources[J]. China J Chin Mater Med, 2009, 34(15): 1879-1885.
    [15] 国家重点保护野生动物名录[J]. 环境教育, 2008(4): 82.

    List of national key protected wild animals[J]. Environ Educ, 2008(4): 82.
    [16] 农文. 国家就禁止犀牛角和虎骨贸易发出善后处理通知[J]. 中国中医药信息杂志, 1995, 2(5): 4.

    NONG W. The state issued a notice on the aftermath of the ban on the trade of rhinoceros horn and tiger bone[J]. Chin J Inf TCM, 1995, 2(5): 4.
    [17] 赵润怀, 贾海彬, 周永红, 等. 我国动物药资源供给现状及可持续发展的思考[J]. 中国现代中药, 2020, 22(6): 835-839.

    ZHAO RH, JIA HB, ZHOU YH, et al. Combination of protection and development is the way to solve the dilemma of sustainable utilization of animal medicine[J]. Mod Chin Med, 2020, 22(6): 835-839.
    [18] 蒋志刚. 论《濒危野生动植物种国际贸易公约》物种概念的内涵和外延[J]. 生物多样性, 2017, 25(1): 88-90.

    JIANG ZG. On the connotation and extension of species concept used by the Convention on International Trade in Endangered Species of Wild Fauna and Flora(CITES)[J]. Biodivers Sci, 2017, 25(1): 88-90.
    [19] 金政, 吴彤, 吴伟, 等. 邓铁涛运用中药代品经验[J]. 中医杂志, 2017, 58(4): 285-286, 299.

    JIN Z, WU T, WU W, et al. DENG Tietao's experience in using Chinese medicine substitutes[J]. J Tradit Chin Med, 2017, 58(4): 285-286, 299.
    [20] 国务院关于发展中药材生产问题的指示[J]. 中华人民共和国国务院公报, 1958(33): 689-692.

    Instructions of the state council on developing the production of traditional Chinese medicine[J]. Gazette State Counc PRC, 1958(33): 689-692.
    [21] 杨藻之, 王大中. 四川省养獐取麝的经验[J]. 中国药学杂志, 1959(5): 230-231.

    YANG ZZ, WANG DZ. Experience of raising Deer and taking musk Deer in Sichuan Province[J]. Chin Pharm J, 1959(5): 230-231.
    [22] 王建明, 戴晓阳, 张争明. 麝香可持续利用的探讨[J]. 经济动物学报, 2014, 18(4): 187-192, 184.

    WANG JM, DAI XY, ZHANG ZM. Sustainable use of musk[J]. J Econ Animal, 2014, 18(4): 187-192, 184.
    [23] 郑程莉, 赵润怀, 孟智斌, 等. 我国人工养麝现状分析及展望[J/OL]. 中国现代中药: 1-9[2022-09-05].
    [24] 农业农村部办公厅. 农业农村部办公厅关于贯彻落实《国家重点保护野生动物名录》加强水生野生动物保护管理的通知[J]. 中华人民共和国农业农村部公报, 2021(4): 105-106.

    General Office of the Ministry of Agriculture and Rural Affairs. Circular of the General Office of the Ministry of Agriculture and Rural Affairs on adopting the Lists of Wild Animals under Special State Protection in China and strengthening aquatic wildlife protection management[J]. Gazette Minist Agric Rural Aff PRC, 2021(4): 105-106.
    [25] 石岩, 邹秦文, 魏锋, 等. 熊胆粉药材研究进展[J]. 中国药事, 2014, 28(1): 82-85.

    SHI Y, ZOU QW, WEI F, et al. The research progress in bear gall powder[J]. Chin Pharm Aff, 2014, 28(1): 82-85.
    [26] 滕毅, 杨海玲. 我国养熊业及引流取胆技术的历史与发展现状[J]. 中国中医药信息杂志, 2010, 17(4): 8-9.

    TENG Y, YANG HL. History and development status of bear breeding and bile drainage technology in China[J]. Chin J Inf Tradit Chin Med, 2010, 17(4): 8-9.
    [27] 李新月, 苏芳芳, 蒋超, 等. 中药熊胆资源发展历程与展望[J]. 中国中药杂志, 2022, 47(16): 4284-4291.

    LI XY, SU FF, JIANG C, et al. Development history and prospect of Fel Ursi[J]. China J Chin Mater Med, 2022, 47(16): 4284-4291.
    [28] 郭希清, 叶婧, 李金钢. 虎骨及其替代品的研究进展[J]. 陕西师范大学学报(自然科学版), 2006, 34(S1): 218-221.

    GUO XQ, YE J, LI JG. Research progress on the skeleton of tiger and its substitute[J]. J Shaanxi Norm Univ Nat Sci Ed, 2006, 34(S1): 218-221.
    [29] 索有瑞, 张宝琛, 汪汉卿. 塞隆骨与虎骨中矿物质元素的比较[J]. 中草药, 2004, 35(4): 445-448.

    SUO YR, ZHANG BC, WANG HQ. Comparison on mineral elements in bone of Sailong and tiger[J]. Chin Tradit Herb Drugs, 2004, 35(4): 445-448.
    [30] 刘睿, 段金廒, 李友宾, 等. 水牛角主要药效学评价及解热活性物质基础研究[J]. 南京中医药大学学报, 2007, 23(5): 297-301.

    LIU R, DUAN JA, LI YB, et al. Pharmacodynamics research of water buffalo horn and the basic study of water baffulo horn antipyretic active compound[J]. J Nanjing Univ Tradit Chin Med, 2007, 23(5): 297-301.
    [31] 王斐, 段金廒, 钱大玮, 等. 犀角及羚羊角替代资源的寻找与评价研究(Ⅱ)[J]. 南京中医药大学学报, 2007, 23(1): 36-39.

    WANG F, DUAN JA, QIAN DW, et al. Searching for substitutes for Cornu rhinoceri asiatici and Cornu saigae tataricae and evaluation(Ⅱ)[J]. J Nanjing Univ Tradit Chin Med, 2007, 23(1): 36-39.
    [32] 张学延, 王天明, 吴家胜, 等. 熊胆及其潜在替代资源研究概况[J]. 上海中医药杂志, 2017, 51(9): 114-117.

    ZHANG XY, WANG TM, WU JS, et al. Review on bear bile and its potential alternative resources[J]. Shanghai J Tradit Chin Med, 2017, 51(9): 114-117.
    [33] 鄢海燕, 邹纯才. 熊胆粉与其他三种动物胆粉的FT-IR特征分析及药理作用比较[J]. 皖南医学院学报, 2012, 31(2): 109-111, 115.

    YAN HY, ZOU CC. Characteristic analysis by FT-IR for bile powder from bear and three other animals and comparison of the pharmacological effects[J]. Acta Acad Med Wannan, 2012, 31(2): 109-111, 115.
    [34] 刘逊, 周扬, 朱晔, 等. 穿山甲、猪蹄甲、羊蹄甲炮制品水溶性成分的比较研究[J]. 中华中医药杂志, 2021, 36(1): 472-476.

    LIU X, ZHOU Y, ZHU Y, et al. Comparative study among water-soluble components of processed products of pangolin scales, pig nail and sheep nail[J]. China J Tradit Chin Med Pharm, 2021, 36(1): 472-476.
    [35] 郑希林. 麝香药理及代用品的研究近况[J]. 山东中医杂志, 1991, 10(2): 42-44.

    ZHENG XL. Research status of pharmacology and substitutes of musk[J]. Shandong J Tradit Chin Med, 1991, 10(2): 42-44.
    [36] 谢宗万. 中药品种理论研究[M]. 北京: 中国医药出版社, 1991.

    XIE ZW. Study on variety theory of traditional Chinese medicine[M]. Beijing: Traditional Chinese medicine press, 1991.
    [37] 武文星, 刘睿, 赵晶晶, 等. 山羊角药用价值的研究进展[J]. 中草药, 2022, 53(9): 2825-2838.

    WU WX, LIU R, ZHAO JJ, et al. Research progress on medicinal value of goat horn[J]. Chin Tradit Herb Drugs, 2022, 53(9): 2825-2838.
    [38] 陈芙蓉, 商丹丹, 姜溪, 等. 山羊角替代羚羊角的实验研究[J]. 药物评价研究, 2015, 38(1): 49-52.

    CHEN FR, SHANG DD, JIANG X, et al. Experimental study on horns of Capra hircus instead of horns of Saiga tataria[J]. Drug Eval Res, 2015, 38(1): 49-52.
    [39] 刘睿, 朱振华, 吴佳, 等. 羚羊角与山羊角蛋白质类成分比较研究[J]. 中国中药杂志, 2018, 43(16): 3329-3334.

    LIU R, ZHU ZH, WU J, et al. Comparison on proteins of saigae tataricae Cornu and caprae hircus Cornu[J]. China J Chin Mater Med, 2018, 43(16): 3329-3334.
    [40] 张能荣. 人工牛黄的再研究[J]. 北京医药, 1989(3): 15-20.

    ZHANG NR. re-study of artificial bezoar[J]. Beijing Pharm, 1989(3): 15-20.
    [41] 唐德煊. 我们是怎样合成牛黄的?[J]. 上海中医药杂志, 1957(11): 12-14.

    TANG DX. How do we synthesize bezoar?[J]. Shanghai J Tradit Chin Med, 1957(11): 12-14.
    [42] 李南. 人工合成牛黄主要成份初探[J]. 生化药物杂志, 1989, 9(3): 27-30.

    LI N. Preliminary study on the main components of artificial bezoar[J]. Chin J Biochem Pharm, 1989, 9(3): 27-30.
    [43] 龚逸民, 钱涌, 黄泽. 新部颁标准人工牛黄的特点[J]. 中成药, 1998, 20(2): 44-45.

    GONG YM, QIAN Y, HUANG Z. Characteristics of newly issued standard artificial bezoar[J]. Chin Tradit Pat Med, 1998, 20(2): 44-45.
    [44] 我国研制成功人工虎骨粉: 药理及安全性指标与天然虎骨基本一致[J]. 中国新药杂志, 2003, 12(9): 5.

    The artificial tiger bone powder successfully developed in China-its pharmacological and safety indexes are basically the same as those of natural tiger bone[J]. Chin New Drugs J, 2003, 12(9): 5.
    [45] 于淑贤, 高颖. 天然与人工熊胆粉的药效学实验研究[J]. 吉林中医药, 2005, 25(3): 55-60.

    YU SX, GAO Y. Experimental study on pharmacodynamics of natural bear bile powder and artificial[J]. J Tradit Chin Med Chin Mater Med Jilin, 2005, 25(3): 55-60.
    [46] 马宏跃, 李念光, 段金廒, 等. 一种蟾毒色胺及其季铵盐的合成方法和在制备镇痛、抗炎药物中的应用:

    CN110776454B[P]. 2021-03-23. MA HY, LI NG, DUAN JA, et al. Synthesis method of bufotenin and quaternary ammonium salt thereof and application in preparation of analgesic and anti-inflammatory drugs: CN110776454B[P]. 2021-03-23.
    [47] SHEN LL, LV X, YANG X, et al. Bufotenines-loaded liposome exerts anti-inflammatory, analgesic effects and reduce gastrointestinal toxicity through altering lipid and bufotenines metabolism[J]. Biomed Pharmacother, 2022, 153: 113492.
    [48] BERGMANN C, DODT J, KÖHLER S, et al. Chemical synthesis and expression of a gene coding for hirudin, the thrombin-specific inhibitor from the leech Hirudo medicinalis[J]. Biol Chem Hoppe Seyler, 1986, 367(8): 731-740.
    [49] 申同健, 葛庆远, 韩玉珉, 等. 人工合成的水蛭素基因在酵母中的表达[J]. 中国科学(B辑: 化学), 1991(8): 818-823.

    SHEN TJ, GE QY, HAN YM, et al. Expression of synthetic hirudin gene in yeast[J]. Sci China Ser B: Chem, 1991(8): 818-823.
    [50] 陆锦遥, 王琼, 王优杰, 等. 体外培育熊胆粉对小鼠中枢神经系统作用的一般药理学研究[J]. 药学研究, 2020, 39(6): 317-319, 330.

    LU JY, WANG Q, WANG YJ, et al. General pharmacology study on the effect of Bear Bile Powder cultivatedin vitro on the central nervous system of mice[J]. J Pharm Res, 2020, 39(6): 317-319, 330.
    [51] 季庆治, 谭君, 祝连彩, 等. 双酶联合转化鸡胆粉中牛磺鹅去氧胆酸[C]//石家庄: 2014年中国药学大会暨第十四届中国药师周论文集, 2014: 781-782.

    JI QZ, TAN J, ZHU LC, et al. Conversion of taurogodeoxycholic acid in chicken bile powder with double enzyme[C]//Shijiazhuang: Proceedings of the 2014 Chinese Pharmaceutical Congress and the 14th Chinese Pharmacist Week, 2014: 781-782.
    [52] LANCASTER MA, KNOBLICH JA. Organogenesis in a dish: Modeling development and disease using organoid technologies[J]. Science, 2014, 345(6194): 1247125.
    [53] POST Y, PUSCHHOF J, BEUMER J, et al. Snake venom gland organoids[J]. Cell, 2020, 180(2): 233-247.
    [54] Saving rhinos with 3D printed horns[J]. Nat Biotechnol, 2015, 33(7): 683.
    [55] 国务院. 国务院关于印发中医药发展战略规划纲要(2016-2030年)的通知[EB/OL]. (2005-07-12)[2022-08-15]http://www.gov.cn/zhengce/content/2016-02/26/content_5046678.htm.

    State Council. The State Council issued a circular on the Outline of the Strategic Plan for the Development of Traditional Chinese Medicine (2016-2030)[EB/OL]. (2005-07-12)[2022-08-15]http://www.gov.cn/zhengce/content/2016-02/26/content_5046678.htm.
    [56] 国家药品监督管理局. 关于牛黄及其代用品使用问题的通知[EB/OL]. (2004-01-21)[2022-08-15]https://www.nmpa.gov.cn/xxgk/fgwj/gzwj/gzwjyp/20040121010101169.html.

    National Medical Products Administration. Notice concerning the Use of bezoar and its Substitutes[EB/OL]. (2004-01-21)[2022-08-15]https://www.nmpa.gov.cn/xxgk/fgwj/gzwj/gzwjyp/20040121010101169.html.
  • 加载中
图(3)
计量
  • 文章访问数:  351
  • HTML全文浏览量:  111
  • PDF下载量:  39
  • 被引次数: 0
出版历程
  • 收稿日期:  2022-08-15
  • 网络出版日期:  2022-10-25
  • 发布日期:  2022-10-10

目录

    /

    返回文章
    返回